Brief: Trisalus Life Sciences To Become Publicly Traded Through Merger

TriSalus Life Sciences

14/11/2022 13:17

Nov 14 (Reuters) - Medtech Acquisition Corp  MTAC.O :
    * TRISALUS LIFE SCIENCES TO BECOME PUBLICLY TRADED THROUGH
MERGER
WITH MEDTECH ACQUISITION CORPORATION
    * MEDTECH ACQUISITION CORP - EXPECTED CASH AT CLOSING
INCLUDES UP
TO $50 MILLION FROM AN ANTICIPATED CONVERTIBLE NOTE FROM LEADING
INSTITUTIONAL INVESTOR
    * MEDTECH ACQUISITION CORP - TRANSACTION REPRESENTS A
POST-TRANSACTION MARKET CAPITALIZATION OF APPROXIMATELY $244.4
MILLION FOR TRISALUS UPON CLOSING
    * MEDTECH ACQUISITION - COMBINED CO WILL BE A PUBLICLY
TRADED
COMP, COMMON STOCK IS EXPECTED TO BE LISTED ON NASDAQ STOCK
EXCHANGE UNDER TICKER "TLSI"
    * MEDTECH ACQUISITION CORP - AT COMPLETION OF TRANSACTION,
COMPANY
EXPECTS TO HAVE AT LEAST $60 MILLION IN CASH, ASSUMING
SIGNIFICANT REDEMPTIONS
    * MEDTECH ACQUISITION CORP - LONGER TERM, TRINAV IS EXPECTED
TO
SUPPORT GROWTH AND EFFECTIVENESS OF SD-101

Source text for Eikon:  ID:nBw8Vb050a 
Further company coverage:  MTAC.O 
 ((Reuters.Briefs@thomsonreuters.com;))